| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.6144 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.6327 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.7462 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.7464 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.7509 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.7689 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.7966 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.8027 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.8051 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.8245 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.8649 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.8760 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.8870 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.8939 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 0.9299 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.0701 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.0779 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.1149 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.1243 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.3890 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.4714 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.5425 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.6857 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.7245 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.8112 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 1.8626 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 2.0165 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 2.0515 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 2.2099 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4)* | 2.2825 | relative value | MCT-Vehicle |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|